Independent site. Not an official website of the Northern Ireland Assembly. Find out more
Asked by Andrew Muir

AQW 3085/22-27 Written question to the Minister of Health

To ask the Minister of Health what advice was given to Trusts when the Essure implant device was withdrawn from the market in 2017 by its manufacturer, Bayer.

Asked by Andrew Muir MLA on 8 September 2022

  • Answered
  • Written
Tabled
8 September 2022
Answer due by
26 September 2022
Answered
21 September 202213 days after tabling
Department
Department of Health
Priority question
No

Answer

Following the suspension of the Essure device’s CE mark on 3 August 2017, the Department advised the Health and Social Care Trusts on 18th August 2017 to suspend use of the Essure device and quarantine any remaining inventory. This was by means of an email from the Northern Ireland Adverse Incident Centre to Trust medical device liaison officers. The manufacturer’s Field Corrective Action to their customers at this time requested a voluntary suspension of use of the product and to temporarily quarantine any unused inventory until further notice.

Official sources

  • AQW 4896/22-27To ask the Minister of Health for an update on the appointment of a replacement contractor for Priory and Springhill GP Surgeries.
  • AQW 4059/22-27To ask the Minister of Health how his Department monitors the number of Dental Surgeries in Northern Ireland that accept new NHS patients.
  • AQW 4058/22-27To ask the Minister of Health (i) how many dental surgeries in North Down are currently accepting new NHS registered patients; and (ii) w…
  • AQW 3086/22-27To ask the Minister of Health what support is available for women who suffered side-effects, the risk of which they were not made aware,…
  • AQW 1488/22-27To ask the Minister of Health, pursuant to AQW 320/22-27, to outline the timescales for resolving issues uncovered by GP practice visits.